Mr. Johann Tergesen reports

BURCON ANNOUNCES COMPLETION OF OVER-SUBSCRIBED RIGHTS OFFERING

Burcon NutraScience Corp. has completed its previously announced offering of rights to holders of its common shares of record at the close of business on April 2, 2015. The rights offering was fully subscribed, and as such, Burcon has issued 1,552,044 common shares at a price of $2.26 per common share for aggregate gross proceeds to Burcon of $3,507,619.

The rights offering was oversubscribed by $6,099,586 or 2,698,932 common shares, due to the demand for the common shares. Total subscriptions, including those exercised pursuant to the additional subscription privilege, represented $9,607,206, or more than 270 per cent of the common shares available under the rights offering.

Each of ITC Corp. Ltd., E-Concept Ltd. and I-Global Ltd. acted as a guarantor of the rights offering, having agreed to purchase from Burcon such number of common shares available to be purchased, but not otherwise subscribed for, that would result in 1,552,044 common shares being issued under the rights offering. As the rights offering was oversubscribed, ITC, E-Concept and I-Global were not required to fulfill their respective obligations under the standby commitment. However, to Burcon's knowledge, each of ITC, E-Concept and I-Global did exercise its basic subscription privilege under the rights offering in order to maintain its respective proportionate ownership interest in Burcon.

As compensation for providing the standby commitment, each of ITC, E-Concept and I-Global has received non-transferrable common share purchase warrants, entitling ITC to acquire up to 198,429 common shares, E-Concept to acquire up to 104,220 common shares and I-Global to acquire up to 85,362 common shares. The exercise price under the standby warrants is $2.26 per common share. The standby warrants will expire two years after issuance. In accordance with the policies of the Toronto Stock Exchange, the issuance of the standby warrants to each of ITC, E-Concept and I-Global is subject to shareholder approval, which will be sought at Burcon's next annual meeting, which is expected to be held in September, 2015.

The net proceeds to Burcon from the rights offering will be used by Burcon for continued research and development of its pea and soy protein extraction and purification technologies, commercialization of Burcon's pea protein extraction and purification technology, filing new patent applications, maintaining, strengthening and expanding Burcon's intellectual property portfolio, pursuing product development agreements with major food, beverage and nutritional product companies, continued research and development of Burcon's other protein extraction and purification technologies, and general working capital.

We seek Safe Harbor.